Damon Runyon Cancer Research Foundation
Damon Runyon Clinical Investigator Award
 |
|
|
|
|
|
||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||
Sponsors website
Internal deadline: Jan. 12 , 2009 4 p.m.
(see internal submission guidelines below)
Number of applicants: 2 (an internal selection process is required)
Amount of funding
The $450,000 Award will be for a period of three years. Annually, funding of $150,000 ($100,000 stipend and $50,000 research allowance) will be allocated to the awardee's institution for the specific support of the Clinical Investigator. A portion of the stipend may be applied to research costs upon request. No part of this award can be used for indirect costs or institutional overheard.
Debt Repayment Program: The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any medical school debt still owed by the awardee.
Important: Please see the Stanford clarifications to the sponsor's eligibility requirements stated below.
- The applicant must be a U.S. citizen or permanent legal resident..
- The applicant must have received an MD or MD/PhD degree(s) from an accredited institution and be board-eligible.
- The applicant must be involved in patient-oriented cancer research. (See the definition of Clinical Research below.)
- Stanford Clarification #1: As of the application date, March 2, 2009, applicants must be within the first four years of their initial assistant professorship appointment (MCL or UTL appointments permitted.) Please use the date the Provost Office approved your formal UTL or MCL faculty appointment. Time spent in your acting assistant professor appointment is not counted because. If you were an assistant professor at another institution prior to coming to Stanford then the overall time from the date of that initial appointment at the other institution must be within four years as of March 2, 2009.
- Stanford clarification #2: Per correspondence with the sponsor, Stanford "Instructors" with M.D.s, or M.D./Ph.D.'s may apply only if they have a long term commitment from Stanford (i.e., their paperwork for an assistant professor appointment is in process).
- During each year of the award, the applicant must commit a minimum of 80% of their professional effort to the conduct of research and research career development.
- Individuals must be involved in clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems.
- The institution will be expected to guarantee the allocation of sufficient research and office space to ensure the proper start-up of the awardee and allow them to devote 80% of their time to research. In addition the institution must provide the difference in salary between the amount allocated by the award and the level appropriate for the position the applicant holds at that institution.
- Mentor: The applicant is required to apply in conjunction with a mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time. The Mentor's role is to foster the development of the applicant's knowledge, technical and analytical skills, and capacity for scientific inquiry in the field of human disease-oriented clinical and translational research. The Mentor also acts as an advocate for the applicant at the departmental, institutional, and professional levels.
- Other Funding Restrictions:
- The Clinical Investigator is expected and encouraged to develop other sources of funding for their overall research program during the time not allocated to this research proposal.
- Candidates holding or awarded R01s at the time of the application are not eligible to apply.
- Physician-scientist career development awards from the federal government including the National Institutes of Health (e.g. K-08, K-12, K-23), the Department of Defense, and the U.S. Department of Veterans Affairs are allowed.
- Scientific or budgetary overlap with other funded projects is not allowed.
- However, no other salary and/or named award expressly intended for clinical career development may be held concurrently with the Clinical Investigator Award.
Examples of awards that cannot be held concurrently with the Damon Runyon Clinical Investigator Award include (but are not limited to):
American Cancer Society - Mentored Research Scholar Grant in Applied and Clinical Research
ASCO - Career Development Award
Burroughs Wellcome Fund - Career Awards for Medical Scientists
Doris Duke Charitable Foundation - Clinical Scientist Development Award
Howard Hughes Medical Institute-Physician-Scientists Early Career Award, Early Career Scientist Competition
Kimmel Foundation - Kimmel Translational Science Award, Kimmel Scholar Award
Leukemia and Lymphoma Society - Career Development Program, Scholar Awards
The Damon Runyon Clinical Investigator Award supports young physician-scientists conducting patient-oriented cancer research. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments. (Eli Lilly, Seimens Medical Solutions, Novartis and Genentech are sponsors of this funding opportunity.) The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming independent clinical investigators.
In light of the Foundation's partnership with Siemens Medical Solutions, in addition to candidates working in translational clinical oncology, the Foundation is interested in candidates whose research relates to or uses imaging technologies and molecular imaging in cancer.
Definition of Clinical Research
(a) Patient-oriented research: Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: patient-based studies of mechanisms of human disease, diagnostic and therapeutic interventions, clinical trials and development of new technologies for the detection, treatment and prevention of human cancers.
(b) Epidemiologic and behavioral studies.
(c) Outcomes research and health services research.Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, clinical or patient-oriented research is research in which it is necessary to know the identity of the patient(s) from whom the cells or tissues under study are derived.
Preference will be given to research that adheres to the "Handshake Rule," meaning that the physician will meet each patient in their research studies.
Selection Process
- Excellence of the applicant and mentor.
Innovation, creativity, quality and originality of the research proposal.
- The commitment of the mentor and institution to the development and training of the applicant as an independent clinical research investigator.
- Evidence of the applicant's commitment to clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems.
- Importance of the proposed research to the field of cancer and/or cancer prevention.
- Adherence of the proposal to the definition of clinical research (as defined by this announcement)
- Adherence to the "Handshake Rule." meaning that the physician will meet each patient in their research studies.
Internal submission guidelines: Internal
deadline
By Monday, Jan.. 12, 2009, 4 p.m., please deliver one original and 8 sets of copies
(Please clip, but do not staple the original. Each of the 8 sets of copies should include the nomination letter, research proposal and biosketches-then staple each set) (keep in mind one set goes to each committee member) to:
Jeanne Heschele, Research Management Group.
Jeanne will be at RMG's former location at 1215 Welch Road, Modular B, Room 20 to accept proposals between 2pm and 4 p.m. on Monday, Jan. 12, 2009.Please send an email notifying Jeanne at jheschele@stanford.edu regarding your plans to submit a proposal. She can also be reached on her cell phone at 650-245-2351.
(No budgets or SU-42 forms are required for this gift funding opportunity.)
1) Nomination letter (REVISED) prepared by your mentor printed on your department letterhead addressed to the Cancer Center Internal Review Committee signed by your mentor, division chief and department chair. Your selection must confirm that the nominee must commit a minimum of 80% of their professional effort to the conduct of research and research career development. Likewise, the letter must address the various items listed under "Selection Criteria" above.
2) 4 page Research Proposal (illustrations & references not included in page total)
Font size at least 11 with half-inch margins.
3) 4-6 page NIH-format biosketch (with Other funding--current and pending, sponsor, amount of funding, term as well as start up funds.)
Selection process (REVISED):
The Cancer Center Internal Review Committee will select 2 applicants to represent the School of Medicine by the sponsor's March 2, 2009 deadline.
